bioMérieux S.A.

Paris Stock Exchange:BIM.PA

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

🏥 Hospitals & Clinics

🩺 Medical Instruments

Location

France

Market Cap

USD 16.52 B

Share Price

USD 139.42

Avg Daily Volume

126,647

Change (1 day)

-0.45%

Change (1 year)

44.41%

Change (YTD)

30.09%

bioMérieux S.A. Common Stock Issued for the year ending December 31, 2024: USD 0.00

bioMérieux S.A. Common Stock Issued is USD 0.00 for the year ending December 31, 2024, a -100.00% change year over year. Common stock issued is cash received from issuing new shares of the company’s common stock.

bioMérieux S.A. Common Stock Issued for the year ending December 31, 2023 was USD 14.02 M.
bioMérieux S.A. Common Stock Issued for the year ending December 31, 2022 was USD 0.00.
bioMérieux S.A. Common Stock Issued for the year ending December 31, 2021 was USD 0.00.
bioMérieux S.A. Common Stock Issued for the year ending December 31, 2020 was USD 0.00.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Common Stock Issued	Common Stock Repurchased	Free Cash Flow	Operating Cash Flow

Paris Stock Exchange: BIM.PA

bioMérieux S.A.

CEO	Mr. Pierre Boulud
IPO Date	July 7, 2004
Location	France
Headquarters	376 Chemin De l'Orme
Employees	14,147
Sector	🏥 Health Care
Industries Biotechnology 🔬 Clinical Trials 🏥 Hospitals & Clinics 🩺 Medical Instruments

Description

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.